According to Heron Therapeutics's latest financial reports the company's current revenue (TTM) is $0.12 B. In 2022 the company made a revenue of $0.10 B an increase over the years 2021 revenue that were of $86.34 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.12 B | 17.99% |
2022 | $0.10 B | 24.7% |
2021 | $86.34 M | -2.59% |
2020 | $88.63 M | -39.28% |
2019 | $0.14 B | 88.41% |
2018 | $77.47 M | 151.81% |
2017 | $30.76 M | 2305.55% |
2016 | $1.27 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | -100% |
2011 | $0.64 M | -50.35% |
2010 | $1.3 M | 3.17% |
2009 | $1.26 M | 240.81% |
2008 | $0.37 M | |
2005 | $5.39 M | -0.24% |
2004 | $5.4 M | 11.45% |
2003 | $4.84 M | -12.31% |
2002 | $5.53 M | 26.05% |
2001 | $4.38 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
SurModics SRDX | $0.13 B | 8.78% | ๐บ๐ธ USA |
Pacira Biosciences
PCRX | $0.67 B | 431.29% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $0.13 B | 3.36% | ๐บ๐ธ USA |
Alkermes ALKS | $1.66 B | 1,209.31% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | $90.12 M | -29.06% | ๐บ๐ธ USA |